AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
The brand has launched 6 new range of products to provide a complete pregnancy care solution
The cognitively operated system is a mother patent invention, first launched in India
Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
The company has secured 506 marketing approvals for its oncology products across 76 countries.
KEYTRUDA plus concurrent chemoradiotherapy demonstrated statistically significant and clinically meaningful improvement in PFS versus concurrent chemoradiotherapy alone in these patients
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
Subscribe To Our Newsletter & Stay Updated
